Showing results (391-400 of 427) with videos related to

Sort By:
Pageof 43
Journal of Hepatology|August 22, 2025
Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitisFabio Del Zompo, Emilie Crouchet, Tessa Ostyn, et al.
Journal of Autoimmunity|September 25, 2019
The challenges of primary biliary cholangitis: What is new and what needs to be doneBenedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani, et al.
Journal of Hepatology|May 5, 2025
New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomasIrene Olaizola, Mikel Odriozola-Gimeno, Paula Olaizola, et al.
Annals of Surgical Oncology|June 19, 2024
Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized DiseaseAnne-Marleen van Keulen, Stefan Buettner, Pim B Olthof, et al.
HGG Advances|June 30, 2024
Stratified analyses refine association between TLR7 rare variants and severe COVID-19Jannik Boos, Caspar I van der Made, Gayatri Ramakrishnan, et al.
Hepatology Communications|February 5, 2024
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statementHannes Hagström, Leon A Adams, Alina M Allen, et al.
Cell Death & Disease|May 29, 2021
Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activityPablo Fernández-Tussy, Rubén Rodríguez-Agudo, David Fernández-Ramos, et al.
Nature Reviews. Gastroenterology & Hepatology|July 2, 2020
Cholangiocarcinoma 2020: the next horizon in mechanisms and managementJesus M Banales, Jose J G Marin, Angela Lamarca, et al.
Molecular Metabolism|June 21, 2021
Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axisMarina Serrano-Maciá, Jorge Simón, Maria J González-Rellan, et al.
Pageof 43